REUTERS: A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay US$27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto.
The jury slapped the companies, which jointly developed the blood thinner, with US$1.8 million in compensatory and US$26 million in punitive damages, according to the couple's lawyer.
The verdict marks the first trial loss in litigation over Xarelto. Bayer and J&J have won three previous cases in federal court.
(This version of the story corrects headline to US$28 million instead of US$29 million, corrects paragraph 2 to US$1.8 million compensatory and US$26 million punitive instead of US$26 million compensatory and US$1.8 million punitive)